LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

Search

Aurinia Pharmaceuticals Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

8.18 1.36

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

8.08

Max

8.33

Pagrindiniai rodikliai

By Trading Economics

Pajamos

22M

23M

Pardavimai

2.6M

62M

P/E

Sektoriaus vid.

29.482

51.198

Pelnas, tenkantis vienai akcijai

0.16

Pelno marža

37.371

Darbuotojai

130

EBITDA

15M

22M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+20.52% upside

Dividendai

By Dow Jones

Kitas uždarbis

2025-07-31

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-53M

1.1B

Ankstesnė atidarymo kaina

6.82

Ankstesnė uždarymo kaina

8.18

Naujienos nuotaikos

By Acuity

50%

50%

167 / 380 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Bullish Evidence

Aurinia Pharmaceuticals Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-06-05 20:45; UTC

Uždarbis

Broadcom 2Q Sales Climb on Booming AI Demand

2025-06-05 23:45; UTC

Rinkos pokalbiai

Nikkei May Decline as Caution Over U.S. Economy Continues -- Market Talk

2025-06-05 23:44; UTC

Rinkos pokalbiai

Gold Edges Higher on Weak U.S. Data -- Market Talk

2025-06-05 23:30; UTC

Rinkos pokalbiai

NZME Cost Cuts Can Cushion Effect of Weak Market -- Market Talk

2025-06-05 21:32; UTC

Uždarbis

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

2025-06-05 20:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-06-05 20:45; UTC

Uždarbis

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

2025-06-05 20:24; UTC

Uždarbis

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

2025-06-05 20:15; UTC

Uždarbis

Broadcom 2Q Cont Ops EPS $1.03 >AVGO

2025-06-05 20:15; UTC

Uždarbis

Broadcom 2Q Rev $15B >AVGO

2025-06-05 20:15; UTC

Uždarbis

Broadcom 2Q Net $4.97B >AVGO

2025-06-05 20:15; UTC

Uždarbis

Broadcom 2Q Adj EPS $1.58 >AVGO

2025-06-05 20:15; UTC

Uždarbis

Broadcom 2Q EPS $1.03 >AVGO

2025-06-05 20:15; UTC

Uždarbis

Broadcom Sees 3Q Rev $15.8B >AVGO

2025-06-05 20:11; UTC

Įsigijimai, susijungimai, perėmimai

Constellation Energy: Transaction Is Expected to Close in the 4Q >CEG

2025-06-05 20:11; UTC

Įsigijimai, susijungimai, perėmimai

Constellation Energy: Calpine Deal Clears Texas Regulatory Review

2025-06-05 20:11; UTC

Įsigijimai, susijungimai, perėmimai

Constellation Energy: With Approval From PUCT Secured, Transaction Awaits Clearance From NY State Public Service Commission, Federal Energy Regulatory Commission and DOJ >CEG

2025-06-05 19:22; UTC

Rinkos pokalbiai

Oil Futures Resume Upward Moves -- Market Talk

2025-06-05 19:00; UTC

Rinkos pokalbiai

U.S. Natural Gas Settles Lower in Choppy Trade -- Market Talk

2025-06-05 18:32; UTC

Rinkos pokalbiai

Gold Slips After Trump-Xi Call -- Market Talk

2025-06-05 18:26; UTC

Uždarbis

These Stocks Are Moving the Most Today: Broadcom, Tesla, Circle, Brown-Forman, MongoDB, Planet Labs, ChargePoint, Ciena, and More -- Barrons.com

2025-06-05 18:06; UTC

Rinkos pokalbiai

Transpacific Ship Freight Rates Spike on China Tariff Truce -- Market Talk

2025-06-05 16:30; UTC

Įsigijimai, susijungimai, perėmimai

Vallourec Completes The Acquisition Of Thermotite Do Brasil >VK.FR

2025-06-05 16:20; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-06-05 16:18; UTC

Rinkos pokalbiai

U.S. Natural Gas Market Shrugs Off Big Storage Build -- Market Talk

2025-06-05 16:15; UTC

Rinkos pokalbiai

Global Commodities Roundup: Market Talk

2025-06-05 16:12; UTC

Rinkos pokalbiai

Global Energy Roundup: Market Talk

2025-06-05 16:12; UTC

Rinkos pokalbiai

Copper Prices Rise on Positive Signals From Trump on China Trade Talks -- Market Talk

2025-06-05 16:03; UTC

Rinkos pokalbiai

U.S. Diesel, Gasoline Futures Pick Back Up -- Market Talk

2025-06-05 15:49; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

Akcijų palyginimas

Kainos pokytis

Aurinia Pharmaceuticals Inc Prognozė

Kainos tikslas

By TipRanks

20.52% į viršų

12 mėnesių prognozė

Vidutinis 9.75 USD  20.52%

Aukščiausias 11 USD

Žemiausias 8 USD

Remiantis 4 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Aurinia Pharmaceuticals Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

4 ratings

4

Pirkti

0

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

8.1 / 8.21Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Bullish Evidence

Vidutinės trukmės periodas

Strong Bullish Evidence

Ilgalaikis periodas

Bullish Evidence

Rinkos nuotaikos

By Acuity

167 / 380 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States. It offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company was incorporated in 1993 and is headquartered in Edmonton, Canada.